JPRN-UMIN000009218CompletedPhase 4
A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with ankle swelling after lateral ankle sprain injuries. - A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with ankle swelling after lateral ankle sprain injuries.
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •- Patient with a surgical operation of ankle sprains - Patient with history of ankle surgeries or with planned ankle surgeries at the sprain side. - Patient coexisting with arthritis/ Arthritis Charcot-type / diabetic foot/ varicose vein/ etc. - Patient coexisting with systemic or localised edema. - Patient with history of drug-indused hypersensitivity. - Patient coexisting with coagulopathy. - Patient coexisting with aspirin induced asthma or history of the same.
Investigators
Similar Trials
Completed
Phase 4
A Phase IV Clinical Trial of EMPYNASE P Tablets 18000 in Patients with Chronic Respiratory Disease.Patients with expectoration symptom in acute exacerbation of bronchial asthma or chronic obstructive pulmonary disease.JPRN-UMIN000008534Kaken Pharmaceutical Co., LTD.240
Completed
Phase 4
A Phase 4 clinical trial of EMPYNASE P tablets 18000 in patients with chronic sinusitischronic sinusitisJPRN-UMIN000008633KAKEN PHARMACEUTICAL CO., LTD.260
Active, not recruiting
Not Applicable
A Phase III trial assessing the pharmacodynamic efficacy and the tolerability of Grazax® treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis - Grazax® in-seasoEUCTR2007-006009-26-DEALK-Abelló A/S295
Active, not recruiting
Not Applicable
A Phase III trial assessing the pharmacodynamic efficacy and the tolerability of Grazax® treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis - Grazax® in-seasoGrass pollen induced rhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisEUCTR2007-006009-26-ATALK-Abelló A/S250
Recruiting
Phase 1
Perispinal Etanercept therapy in Australian patients with chronic stroke.Chronic StrokeStroke - IschaemicStroke - HaemorrhagicACTRN12615001377527Griffith University80